Rolling Out16h
How a sleep mask for apnea reduces high blood pressure risk
Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...
Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension
Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions associated with excess morbidity and mortality – – Obstructive ...
From sleep programmes to handling emotional trauma, wellness retreats are covering a whole gamut of needs
Discover the evolving landscape of wellness in India, from traditional practices to specialized programs addressing modern ...
Hospital offers program to assist with sleep
Do you experience an inclination for snoring, daytime sleepiness, obesity, high blood pressure, impaired concentration and ...
health.wusf.usf.edu12d
FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
Hindustan Times14d
After US woman, 20, dies of ‘sudden heart attack’, parents start foundation to promote cardiac screening: Report
and conditions like obstructive sleep apnea. Begum also pointed out traditional risk factors, including diabetes, high blood pressure, elevated cholesterol levels, and genetic predispositions to ...
McKnight's Long-Term Care News16d
FDA approves Zepbound for sleep apnea in patients with obesity
(HealthDay News) — The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA). In a news ...
WCVB Channel 5 Boston17d
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.The medicine, part of the class known as GLP-1 ...
The Grand Junction Daily Sentinel18d
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the ...
CNET18d
7 Anti-Snoring Products for a Peaceful Slumber
Snoring can be hard to sleep through, whether you're the person snoring or the partner listening to it all night. From nasal strips to specialty pillows, there are a lot of tools out there to stop ...
Sky18d
Relief as first UK patients fitted with app-controlled sleep apnoea microchip
Some patients die as a result. "In severe untreated obstructive sleep apnoea that can be as high as 1 in 3 within ten years," Mr Cheong said. The most common treatment at present is a Continuous ...
Houston Public Media19d
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...